Genetic risk factors influencing the development of prostate cancer in patients with benign prostatic hyperplasia
The primary aim of this study is to assess the predictive value of six molecular markers in determining PRCa risk in patients with BPH. These molecular markers are: (A)- Two polymorphic repeats, (CAG)<sub>n</sub> and (GGN)<sub>n</sub>, in the androgen receptor (<i>AR<...
Main Author: | Tayeb, Mohammed Taher |
---|---|
Published: |
University of Aberdeen
2002
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248613 |
Similar Items
-
Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01) -
INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: A. I. Neymark, et al.
Published: (2015-09-01) -
EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01) -
Adipocytokine levels in benign prostate hyperplasia and prostate cancer patients
by: Gokhan Temeltas, et al.
Published: (2017-09-01) -
Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)